Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: Implications for CD4+ versus CD8+ lineage commitment

Journal of Immunology

Volumn 176, Issue 3, 2006, Pages 1628-1636

  Eshima, Koji ^a   Suzuki, Harumi ^b   Shinohara, Nobukata ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; INHIBITOR OF DIFFERENTIATION PROTEIN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RAG2 PROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CELL MATURATION; CELL SELECTION; CLONE; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC ANALYSIS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; TRANSGENE; TRANSGENIC MOUSE;

EID: 31144451571     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.3.1628     Document Type: Article

References (54)

1. He, X., X. He, V. P. Dave, Y. Zhang, X. Hua, E. Nicolas, W. Xu, B. A. Roe, and D. J. Kappes. 2005. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 433: 826-833.
2. Sun, G., X. Liu, P. Mercado, S. R. Jenkinson, M. Kypriotou, L. Feigenbaum, P. Galera, and R. Bosselut. 2005. The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat. Immunol. 6: 373-381.
3. Germain, R. N. 2002. T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 2: 309-322.
4. Bosselut, R., and A. Singer. 2004. CD4/CD8 coreceptors in thymocyte development, selection, and lineage commitment: analysis of the CD4/CD8 lineage decision. Adv. Immunol. 83: 91-131.
5. Finberg, R., S. J. Burakoff, H. Cantor, and B. Benacerraf. 1978. Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. Proc. Natl. Acad. Sci. USA 75: 5145-5149.
6. Hunig, T. R., and M. J. Bevan. 1982. Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis. J. Exp. Med. 155: 111-125.
7. Bux, E., K. Matsunaga, T. Nagatani, P. Walden, Z. A. Nagy, and J. Klein. 1985. Distribution of alloreactivity among antigen-specific, class II-restricted T-cell clones and hybridomas. Immunogenetics 22: 189-192.
8. Matis, L. A., S. B. Sorger, D. L. McElligott, P. J. Fink, and S. M. Hedrick. 1987. The molecular basis of alloreactivity in antigen-specific, major histocompatibility complex-restricted T cell clones. Cell 51: 59-69.
9. Udaka, K., K. Wiesmuller, H. Kienle, S. Jung, and P. Walden. 1996. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. J. Immunol. 157: 670-678.
10. Itano, A., P. Salmon, D. Kioussis, M. Tolaini, P. Corbella, and E. Robey. 1996. The cytoplasmic domain of CD4 promotes the development of CD4 lineage T cells. J. Exp. Med. 183: 731-741.
11. Matechak, E. O., N. Killeen, S. M. Hedrick, and B. J. Fowlkes. 1996. MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent. Immunity 4: 337-347.
12. + thymocytes in suspension culture. Eur. J. Immunol. 26: 2081-2086.
13. Ohoka, Y., T. Kuwata, A. Asada, Y. Zhao, M. Mukai, and M. Iwata. 1997. Regulation of thymocyte lineage commitment by the level of classical protein kinase C activity. J. Immunol. 158: 5707-5716.
14. Sharp, L. L., D. A. Schwarz, C. M. Bott, C. J. Marshall, and S. M. Hedrick. 1997. The influence of the MAPK pathway on T cell lineage commitment. Immunity 7: 609-618.
15. + T-cell lineage fate. Nature 404: 506-510.
16. Watanabe, N., H., Arase, M. Onodera, P. S. Ohashi, and T. Saito. 2000. The quantity of TCR signal determines positive selection and lineage commitment of T cells. J. Immunol. 165: 6252-6261.
17. Hernandez-Hoyos, G., S. J. Sohn, E. V. Rothenberg, and J. Alberola-Ila. 2000. Lck activity controls CD4/CD8 T cell lineage commitment. Immunity 12: 313-322.
18. Wilkinson, B., and J. Kaye. 2001. Requirement for sustained MAPK signaling in both CD4 and CD8 lineage commitment: a threshold model. Cell. Immunol. 211: 86-95.
19. lck. Cell 55: 301-308.
20. lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules. J. Exp. Med. 178: 1701-1712.
21. hi thymocytes. J. Exp. Med. 181: 1643-1651.
22. + T cell lineages: a new perspective on thymic commitment and selection. Immunity 2: 413-425.
23. Barthlott, T., H. Kohler, and K. Eichmann. 1997. Asynchronous coreceptor down-regulation after positive thymic selection: prolonged maintenance of the double positive state in CD8 lineage differentiation due to sustained biosynthesis of the CD4 coreceptor. J. Exp. Med. 185: 357-362.
24. + T cells. Immunity 13: 59-71.
25. Bosselut, R., L. Feigenbaum, S. O. Sharrow, and A. Singer. 2001. Strength of signaling by CD4 and CD8 coreceptor tails determines the number but not the lineage direction of positively selected thymocytes. Immunity 14: 483-494.
26. + T cells. J. Exp. Med. 197: 1709-1719.
27. Taniuchi, I., M. Osato, T. Egawa, M. J. Sunshine, S. C. Bae, T. Komori, Y. Ito, and D. R. Littman. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111: 621-633.
28. Sato, T., S. Ohno, T. Hayashi, C. Sato, K. Kohu, M. Satake, and S. Habu. 2005. Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes. Immunity 22: 317-328.
29. Suzuki, H., K. Eshima, Y. Takagaki, S. Hanaoka, M. Katsuki, M. Yokoyama, T. Hasegawa, S. Yamazaki, and N. Shinohara. 1994. Origin of a T cell clone with a mismatched combination of MHC restriction and coreceptor expression. J. Immunol. 153: 4496-4507.
30. Shinkai, Y., G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F. W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
31. + cytolytic T cells. Nature 344: 742-746.
32. Ozato, K., T. H. Hansen, and D. H. Sachs. 1980. Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the product of a third polymorphic locus of the mouse major histocompatibility complex. J. Immunol. 125: 2473-2477.
33. + major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte. Eur. J. Immunol. 27: 55-61.
34. Teh, H. S., H. Kishi, B. Scott, and H. von Boehmer. 1989. Deletion of autospecific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules. J. Exp. Med. 169: 795-806.
35. Takayama, H., H. Kojima, and N. Shinohara. 1995. Cytotoxic T lymphocytes: the newly identified Fas (CD95)-mediated killing mechanism and a novel aspect of their biological functions. Adv. Immunol. 60: 289-321.
36. Wang, J. H., and E. L. Reinherz. 2002. Structural basis of T cell recognition of peptides bound to MHC molecules. Mol. Immunol. 38: 1039-1049.
37. Housset, D., and B. Malissen. 2003. What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity? Trends Immunol. 24: 429-437.
38. Bankovich, A. J., and K. C. Garcia: 2003. Not just any T cell receptor will do. Immunity 18: 7-11.
39. Sim, B. C., D. Lo, and N. R. Gascoigne. 1998. Preferential expression of TCR Vα regions in CD4/CD8 subsets: class discrimination or co-receptor recognition? Immunol. Today 19: 276-282.
40. Correia-Neves, M., C. Waltzinger, D. Mathis, and C. Benoist. 2001. The shaping of the T cell repertoire. Immunity 14: 21-32.
41. Huseby, E. S., J. White, F. Crawford, T. Vass, D. Becker, C. Pinilla, P. Marrack, and J. W. Kappler. 2005. How the T cell repertoire becomes peptide and MHC specific. Cell 122: 247-260.
42. + T cells. J. Immunol. 172: 1000-1008.
43. Serreze, D. V., T. M. Holl, M. P. Marron, R. T. Graser, E. A. Johnson, C. Choisy-Rossi, R. M. Slattery, S. M. Lieberman, and T. P. DiLorenzo. 2004. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice. J. Immunol. 172: 871-879.
44. Logunova, N. N., C. Viret, L. A. Pobezinsky, S. A. Miller, D. B. Kazansky, J. P. Sundberg, and A. V. Chervonsky. 2005. Restricted MHC-peptide repertoire predisposes to autoimmunity. J. Exp. Med. 202: 73-84.
45. Arsov, I., and S. Vukmanovic. 1999. Dual MHC class I and class II restriction of a single T cell receptor: distinct modes of tolerance induction by two classes of autoantigens. J. Immunol. 162: 2008-2015.
46. Heemskerk, M. H., R. A. de Paus, E. G. Lurvink, F. Koning, A. Mulder, R. Willemze, J. J. van Rood, and J. H. Falkenburg. 2001. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc. Natl. Acad. Sci. USA 98: 6806-6811.
47. Huseby, E., J. Kappler, and P. Marrack. 2004. TCR-MHC/peptide interactions: kissing-cousins or a shotgun wedding? Eur. J. Immunol. 34: 1243-1250.
48. Shimizu, T., and S. Takeda. 1997. CD8 T cells from major histocompatibility complex class II-deficient mice respond vigorously to class II molecules in a primary mixed lymphocyte reaction. Eur. J. Immunol. 27: 500-508.
49. Tyznik, A. J., J. C. Sun, and M. J. Bevan. 2004. The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J. Exp. Med. 199: 559-565.
50. -/- mice. J. Immunol. 173: 2494-2499.
51. Liu, X., and R. Bosselut. 2004. Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo. Nat. Immunol. 5: 280-288.
52. Sarafova, S. D., B. Erman, Q. Yu, F. Van Laethem, T. Guinter, S. O. Sharrow, L. Feigenbaum, K. F. Wildt, W. Ellmeier, and A. Singer. 2005. Modulation of coreceptor transcription during positive selection dictates lineage fate independently of TCR/coreceptor specificity. Immunity 23: 75-87.
53. Huesmann, M., B. Scott, P. Kisielow, and H. von Boehmer. 1991. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 66: 533-540.
54. + T cell development in the thymus. Cell 108: 755-767.